Guided Therapeutics (Guided Therapeutics) Growth Rank : 0 (As of May. 05, 2024)

View and export this data going back to 1997. Start your Free Trial

What is Guided Therapeutics Growth Rank?

Guided Therapeutics has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Guided Therapeutics Growth Rank Related Terms

Thank you for viewing the detailed overview of Guided Therapeutics's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Guided Therapeutics (Guided Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guided Therapeutics Inc (OTCPK:GTHP) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

5835 Peachtree Corners East, Suite B, Norcross, GA, USA, 30092

Website

https://www.guidedinc.com

Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.

Executives

John E Imhoff	director, 10 percent owner	P.O. BOX 31083, SEA ISLAND GA 31561
Alan Grujic	director	349 FORBES AVE, SAN RAFAEL CA 94901
Michael C James	director	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Richard P. Blumberg	director	2357 HOBART AVENUE S.W., SEATTLE WA 98116
Lynne H Imhoff	10 percent owner	2716 SOUTH ROCKFORD ROAD, TULSA OK 74114
Gene S Cartwright	officer: Chief Executive Officer	4088 COMMERCIAL AVE, NORTHBROOK IL 60062
Parsons & Whittemore Enterprises Corp.	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
George F. Landegger 2010 10-year Grat	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
George F Landegger	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK, NEW YORK NY 10573
Whittemore Collection Ltd	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
George F. Landegger 2010 5-year Grat	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Linda Rosenstock	director	5995 PLAZA DRIVE, MAIL STOP CY20-103, CYPRESS CA 90630
Jonathan M Niloff	director	C/O MATRITECH, INC., 330 NEVADA STREET, NEWTON MA 02460
Ronald W Allen	director	P O BOX 1734, ATLANTA GA 30301
Shabbir Bakir Bambot	officer: VP of R & D	4955 AVALON RIDGE PARKWAY, SUITE 300, NORCROSS GA 30071

Guided Therapeutics (Guided Therapeutics) Headlines

From GuruFocus

Dr. Gene Cartwright, CEO of Guided Therapeutics Joins Everett Jolly on Uptick Newswire's “Stock Day” Podcast to Discuss LuViva® Advanced Cervical Scan

By Marketwired Marketwired • 05-16-2018